logo-loader
viewCollagen Solutions PLC

Collagen Solutions sees clear path to profitability as commercial development progresses

Collagen Solutions PLC's (LON:COS) Jamal Rushdy and Hilary Spence talk Proactive London's Andrew Scott through the firm's results for the year ended 31 March 2019.

Revenues were up 22% in the year at £4.5mln, while its loss narrowed by just under £500,000 to £1.22mln.

The core business was profitable on an underlying earnings (EBITDA) basis in the final quarter.

Operationally, they landed 29 new customers as it grew its North American business by 72%.

Quick facts: Collagen Solutions PLC

Price: 1.125 GBX

LSE:COS
Market: LSE
Market Cap: £4.99 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Collagen Solutions PLC named herein, including the promotion by the Company of Collagen Solutions PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Collagen Solutions reports strong growth in its tissue business in first half

Collagen Solutions PLC's (LON:COS) Jamal Rushdy and Hilary Spence update Proactive London's Andrew Scott on first half performance - their third consecutive six-month period of double-digit sales growth. Revenues increased by 14% to £2.23mln in the period ended September 30. Tissue sales more...

on 3/12/19

2 min read